Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

Investigation of Safety, Tolerability, Immunogenicity and Pharmacokinetics of Single-Dose of PF-06823859 in Japanese Healthy ParticipantsCompleted
NCT05037409Phase 1Updated Dec 15, 2023
Sponsor: Pfizer
Healthy
Japan
Safety and Efficacy Trial of BHV3000 (Rimegepant) 75 mg for the Acute Treatment of MigraineCompleted
NCT04574362Phase 3Updated Dec 14, 2023
Sponsor: Pfizer
Acute Migraine
China, South Korea
Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia.Completed
NCT04299048Phase 1Updated Dec 14, 2023
Sponsor: Pfizer
Cachexia · Non-Small-Cell Lung Cancer · Pancreatic Cancer · Colorectal Cancer
United States
Lorlatinib in Combination With Chemotherapy in Participants With Metastatic Anaplastic Lymphoma Kinase Positive (ALK+) Non-small Cell Lung Cancer (NSCLC) Who Progressed on Single-agent LorlatinibWithdrawn
NCT05948462Phase 2Updated Dec 13, 2023
Sponsor: SCRI Development Innovations, LLC
Lung Cancer · Non-small Cell Lung Cancer
United States
Oral Psoriasis Treatment Adherence and Intervention StudyCompleted
NCT02850900NAUpdated Dec 13, 2023
Sponsor: Wake Forest University Health Sciences
Psoriasis
United States
Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis.Completed
NCT00393471Phase 3Updated Dec 13, 2023
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Active Rheumatoid Arthritis
Australia, Austria, Belgium, Czechia, Denmark +14 more
A Study Evaluating the Safety, Tolerability, and Effect on Microvascular Obstruction of Intravenous Temanogrel in Adult Participants Undergoing Percutaneous Coronary InterventionTerminated
NCT04848220Phase 2Updated Dec 12, 2023
Sponsor: Pfizer
Microvascular Obstruction
United States, Australia, Netherlands, Sweden, United Kingdom
The Pain App Study: A Novel Shared Decision Making Tool for People With Chronic PainCompleted
NCT03425266NAUpdated Dec 12, 2023
Sponsor: Shared Decision Making Resources
Chronic Pain
United States
Avelumab in the Frontline Treatment of Advanced Classical Hodgkin Lymphoma - a Window StudyUnknown
NCT03617666Phase 2Updated Dec 12, 2023
Sponsor: University College, London
Hodgkin Lymphoma
Australia, United Kingdom
A Study of Palbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and SurgeryCompleted
NCT01864746Phase 3Updated Dec 12, 2023
Sponsor: GBG Forschungs GmbH
Breast Cancer · Hormonreceptor Positive · Her2-normal · Postneoadjuvant Treatment With CDK 4/6 Inhibitor
United States, Australia, Austria, Canada, France +6 more
A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant RecipientsCompleted
NCT00195429Phase 4Updated Dec 11, 2023
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Kidney Failure · Graft vs Host Disease
Brazil
Study Evaluating the Long-Term Safety of Desvenlafaxine Succinate Sustained-Release (DVS SR) in Subjects With Pain Associated With Diabetic Peripheral NeuropathyTerminated
NCT01050218Phase 3Updated Dec 11, 2023
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Diabetic Neuropathy, Painful
CREATE: Cross-tumoral Phase 2 With CrizotinibCompleted
NCT01524926Phase 2Updated Dec 11, 2023
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma · Locally Advanced and/or Metastatic Inflammatory Myofibroblastic Tumor · Locally Advanced and/or Metastatic Papillary Renal Cell Carcinoma Type 1 · Locally Advanced and/or Metastatic Alveolar Soft Part Sarcoma
Belgium, France, Germany, Italy, Netherlands +5 more
Study Comparing Standard Dose and Reduced Dose Tacrolimus With Sirolimus in Renal Transplant PatientsCompleted
NCT00519116Phase 4Updated Dec 11, 2023
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Kidney Transplantation
Study Comparing Graft Function in Renal Allograft Recepients Receiving Reduced or Standard Dose CsA With SirolimusCompleted
NCT00518375Phase 4Updated Dec 11, 2023
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Kidney Transplantation
20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy InfantsCompleted
NCT04382326Phase 3Updated Dec 6, 2023
Sponsor: Pfizer
Pneumococcal Disease
United States, Puerto Rico
Crizotinib in High-Risk Uveal Melanoma Following Definitive TherapyCompleted
NCT02223819Phase 2Updated Dec 6, 2023
Sponsor: Columbia University
Uveal Melanoma
United States
An Observational Chart Review Study To Describe The Real-World Outcomes And Use Of Avelumab In Combination With Axitinib For Treatment Of Patients With aRCC In The UKCompleted
NCT05394493N/AUpdated Dec 6, 2023
Sponsor: Pfizer
Advanced Renal Cell Carcinoma
United Kingdom
Current Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART)Completed
NCT05012865N/AUpdated Dec 6, 2023
Sponsor: Pfizer
Renal Cell Carcinoma
Japan
Central Aspects of Pain in Rheumatoid ArthritisCompleted
NCT04515589N/AUpdated Dec 5, 2023
Sponsor: University of Nottingham
Rheumatoid Arthritis
United Kingdom
FungiScope - A Global Emerging Fungal Infection RegistryRecruiting
NCT01731353N/AUpdated Dec 5, 2023
Sponsor: University of Cologne
Invasive Fungal Disease
Germany
A Study to Evaluate TAlazoparib, Radiotherapy and Atezolizumab in gBRCA 1/2 Negative Patients With PD-L1+ Metastatic Triple Negative Breast CancerTerminated
NCT04690855Phase 2Updated Dec 4, 2023
Sponsor: Mylin A. Torres, MD
Breast Cancer · Triple Negative Breast Cancer
United States
Evaluation of Airway Gene Expression in COPD and Controlled PopulationsTerminated
NCT00571792N/AUpdated Dec 4, 2023
Sponsor: University of Nebraska
COPD
United States
Study To Evaluate The Effect Of Two Steady State Doses of PF 06882961 On Rosuvastatin And Midazolam Pharmacokinetics In Otherwise Healthy Adult Participants With ObesityCompleted
NCT04621227Phase 1Updated Dec 1, 2023
Sponsor: Pfizer
Obesity
United States
A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid TumorsTerminated
NCT03861403Phase 1Updated Nov 30, 2023
Sponsor: Leap Therapeutics, Inc.
Solid Tumors · Advanced Triple Negative Breast Cancer · Advanced Hormone Receptor Positive/Endocrine Refractory Breast Cancer · Advanced Metastatic Castration-Resistant Prostate Cancer
United States

Previous page Next page